LIFELINK VENTURES
LifeLink Ventures is an investment company through which private investors have direct access to exclusive life sciences investments. We look for urgently needed therapies developed by the most driven entrepreneurs and connect them with our network of investors. We believe in the deployment of capital in alignment with a powerful cause – improvement in global health.
LIFELINK VENTURES
Industry:
Life Science
Founded:
2020-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag Mobile Non Scaleable Content
Current Employees Featured
Francisca Peixoto Founder & Investment Manager @ LifeLink Ventures
Founder & Investment Manager
2020-01-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-12-10 | Ochre Bio | LifeLink Ventures investment in Series A - Ochre Bio | N/A |
| 2021-03-25 | Chameleon Biosciences | LifeLink Ventures investment in Seed Round - Chameleon Biosciences | 11.1 M USD |
More informations about "LifeLink Ventures"
about us - LifeLink Ventures
Before joining LifeLink Ventures, Pablo gained practical experience in the venture capital sector through internships at Inveready and Invivo Capital, two reputable Spanish life sciences …See details»
2022 LifeLink Ventures - Annual Report
Values, Green Rock has joined forces with LifeLink in 2022. We are delighted to count on their experience, guidance and support and look forward to building a successful business, side by …See details»
LifeLink Ventures - Crunchbase Investor Profile & Investments
LifeLink Ventures is an investment company through which private investors have direct access to exclusive life sciences investments. We look for urgently needed therapies developed by the …See details»
LifeLink Ventures - LinkedIn
LifeLink Ventures | 905 followers on LinkedIn. Connecting Capital with Purpose | We are an investment firm through which private investors and corporates have direct access to exclusive life ...See details»
LifeLink Ventures - Investments, Portfolio & Company Exits
Oct 1, 2024 LifeLink Ventures has invested in Chameleon Biosciences on Oct 1, 2024. This investment - Seed Round - Chameleon Biosciences - was valued at . obfuscated. obfuscated. …See details»
LifeLink Ventures
LifeLink Ventures is a venture capital firm established in 2020 and based in Barcelona, Spain. The firm specializes in providing private investors access to exclusive investments in the life …See details»
LifeLink Ventures investment portfolio - PitchBook
LifeLink Ventures General Information Company Description. Founded in 2020, LifeLink Ventures is a venture capital firm based in Barcelona, Spain. The firm prefers to invest in early-stage …See details»
LifeLink Ventures | Institution Profile | Private Equity International
LifeLink Ventures. News, insights, analysis and data. LifeLink Ventures overview. LifeLink Ventures is an investment firm based in Barcelona, Spain. The firm invests in venture capital …See details»
2021 LifeLink Ventures - Annual Report SHORT
LifeLink Ventures is an investment company led by private investors. Through LifeLink, they find a doorway to investments with the power to ... LifeLink analysis. 2021 Annual 9 Biotech Report …See details»
LifeLink Ventures - Investor Profile, Portfolio & Team - Tracxn
Mar 21, 2025 LifeLink Ventures is a venture capital firm founded in 2020. It is primarily based out of Barcelona, Spain. As of Oct 2024, LifeLink Ventures is an active investor, having invested in …See details»
LifeLink Ventures - EU-Startups
LifeLink Ventures facilitates direct access for private investors to exclusive life sciences opportunities. They focus on identifying critical therapies led by ambitious entrepreneurs and …See details»
LifeLink Ventures - CB Insights
Sep 30, 2024 LifeLink Ventures is an investment company focused on life sciences and global health improvement. They connect private investors with early-stage biotech companies developing urgently needed therapies, facilitating investments that aim to tackle global health challenges. LifeLink Ventures primarily sells to the biotech and healthcare ...See details»
LifeLink Ventures - Contacts, Employees, Board Members
LifeLink Ventures has 1 current employee profile, Founder & Investment Manager Francisca Peixoto. Francisca Peixoto Founder & Investment Manager Browse By: Organizations, …See details»
Bishop Lyle Dukes - Owner - Mainstream Concepts | LinkedIn
Bishop Lyle Dukes is Senior Pastor and Founder of Harvest Life Changers Church, International, an innovative and progressive ministry of over 7,000 members, located in Woodbridge, Virginia.See details»
QVC Group - Wikipedia
In July 2014, Liberty Interactive announced it would be selling Provide Commerce (parent of ProFlowers) to FTD in return for an equity stake in FTD. [15]In October 2014, Liberty …See details»
for investors - LifeLink Ventures
We source directly from our network of research hubs and academics across Europe, North America and beyond to find the most promising science and drug developers to share with our …See details»
Woodbridge Ventures 2025 Company Profile: Valuation, Investors ...
The current valuation of Woodbridge Ventures is . What is Woodbridge Ventures’s current revenue? The current revenue for Woodbridge Ventures is . How much funding has …See details»
CROSSFIN VENTURES - linkstock.net
Investec Bank Ltd is co-invested in the Ventures structure via its Emerging Companies Private Capital team who chose to back the Crossfin team and story thanks to our considerable track …See details»
Join us - Starboard Ventures
Responsibilities . Responsible for consolidating and planning product requirements, as well as the structuring of product roadmaps. Analyze client demand, industry trends, and competitor …See details»
companies - LifeLink Ventures
Our mission is simple – provide our investors with access to the most promising and impactful life sciences technologies. We focus mostly on early-stage companies developing novel therapies …See details»